What top creators are saying about Remicade
Biologic medicine whose future cash flows were the subject of a Royalty Pharma royalty.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Remicade.
Top creators covering Remicade
The 1 sources with the most insights about Remicade on Kazuha.
Latest insights about Remicade
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Today
Cited as a historical royalty investment that reportedly increased in value about 20 times; this was not a forecast for the medicine or its royalty.
Today
Cited as a historical royalty investment that reportedly increased in value about 20 times; this was not a forecast for the medicine or its royalty.
Discussed alongside Remicade
Other assets that creators frequently mention in the same content as Remicade.
Frequently asked
Which podcasters and creators cover Remicade the most?
The most active sources covering Remicade on Kazuha are All-In Podcast, LLC. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Remicade are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Remicade from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Remicade?
Creators covering Remicade most frequently also discuss BMY, OptiCore, PFE, NVDA, Sparsentan. See the "Discussed alongside" section above for full asset pages.